Variants in the transmembrane 6 superfamily member 2 (TM6SF2) gene are also reported to be associated with disease progression in MASLD, regardless of PNPLA3 polymorphism [8]. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.